Arscience Biotherapeutics

At Arscience Bio, our mission is to expand the boundaries of immunotherapy through customised cytokine solutions designed to enhance the effectiveness of cell therapies and improve patient outcomes. Our focus on developing high-quality interleukins is driven by a passion to better serve the needs of patients across a wide range of diseases, including haematologic malignancies, solid tumours, CNS disorders, and autoimmune diseases. With over 30 years of expertise in cytokines, state-of-the-art cGMP manufacturing facilities, and proprietary formulation IP, we deliver tailored interleukin solutions to meet unique therapeutic needs. Our commercial/clinical-grade IL-2, with over 69,000 doses administered, demonstrates our ability to translate experience and innovation into meaningful therapeutic solutions. By combining extensive expertise in research, development, and manufacturing, we create impactful synergies that drive better outcomes for patients.